These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 16999276)
1. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone]. Nieuwenhuijzen Kruseman AC Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276 [TBL] [Abstract][Full Text] [Related]
2. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial? Black AM; Day AG; Morales A BJU Int; 2004 Nov; 94(7):1066-70. PubMed ID: 15541129 [TBL] [Abstract][Full Text] [Related]
3. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects. Schubert M; Jockenhövel F J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356 [TBL] [Abstract][Full Text] [Related]
4. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Lunenfeld B; Saad F; Hoesl CE Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160 [TBL] [Abstract][Full Text] [Related]
5. Testosterone for 'late-onset hypogonadism' in men? Drug Ther Bull; 2010 Jun; 48(6):69-72. PubMed ID: 20530029 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
7. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism? Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356 [TBL] [Abstract][Full Text] [Related]
8. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints. Permpongkosol S; Tantirangsee N; Ratana-olarn K J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330 [TBL] [Abstract][Full Text] [Related]
9. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism]. Amano T Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219 [TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism. La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link? Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531 [TBL] [Abstract][Full Text] [Related]
12. 'What should I do with a 60-year old man with a slightly low serum total testosterone concentration and normal levels of serum gonadotrophins'? Hugh Jones T Clin Endocrinol (Oxf); 2010 May; 72(5):584-8. PubMed ID: 19878210 [TBL] [Abstract][Full Text] [Related]
13. [Should older men be treated with testosterone?]. Svartberg J Tidsskr Nor Laegeforen; 2005 Apr; 125(7):879-82. PubMed ID: 15815734 [TBL] [Abstract][Full Text] [Related]
14. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity]. Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765 [TBL] [Abstract][Full Text] [Related]
15. The aging male--diagnosis and therapy of late-onset hypogonadism. Schreiber G; Ziemer M J Dtsch Dermatol Ges; 2008 Apr; 6(4):273-9. PubMed ID: 18218041 [TBL] [Abstract][Full Text] [Related]
16. Hypogonadism and metabolic syndrome: implications for testosterone therapy. Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964 [TBL] [Abstract][Full Text] [Related]
17. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies. Turchi P; Simi S; Pescatori ES J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism. Jungwirth A; Plas E; Geurts P Aging Male; 2007 Dec; 10(4):183-7. PubMed ID: 18033627 [TBL] [Abstract][Full Text] [Related]
19. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel. Ebert T; Jockenhövel F; Morales A; Shabsigh R Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407 [TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients. Amano T; Imao T; Takemae K; Iwamoto T; Nakanome M Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]